Rocket


News + Filings
Transactions



EMSTER KURT VON

DateNameSymbolTypeSecuritySharesPriceValueOwnershipReported
06/07/2023Jasper Therapeutics, Inc.AMHCUGrantStock Option (right to buy)47k$1.60$75.2k 06/07/2023
01/25/2023CymaBay Therapeutics, Inc.CBAYGrantStock Option (right to buy)25k$7.80$195k 01/25/2023
10/12/2022Jasper Therapeutics, Inc.AMHCUGrantVoting Common Stock30.2k$0.00$0 10/12/2022
03/21/2022Jasper Therapeutics, Inc.AMHCUGrantStock Option (right to buy)78k$3.54$276.3k 03/21/2022
01/25/2022CymaBay Therapeutics, Inc.CBAYGrantStock Option (right to buy)67k$2.94$197k 01/25/2022
06/02/2021Vaxcyte, Inc.PCVXGrantStock option (right to buy)15k$21.49$322.4k 06/02/2021
05/18/2021Vera Therapeutics, Inc. ConversionClass A Common Stock2.2M$0.00$0See footnote05/17/2021
05/18/2021Vera Therapeutics, Inc. PurchaseClass A Common Stock772.7k$11.00$8.5MSee footnote05/17/2021
05/18/2021Vera Therapeutics, Inc. ConversionSeries C Preferred Stock2.2M$0.00$0See footnote05/17/2021
05/17/2021Vera Therapeutics, Inc. PurchaseClass A Common Stock17.8k$12.04$214.7k 05/17/2021
05/13/2021Vera Therapeutics, Inc. GrantStock Option (right to buy)9.9k$11.00$109.2k 05/13/2021
01/26/2021CymaBay Therapeutics, Inc.CBAYGrantStock Option (right to buy)32k$5.78$185k 01/26/2021
06/16/2020Vaxcyte, Inc.PCVXConversionSeries A Preferred Stock2.2M$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionSeries B Preferred Stock1.2M$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionSeries C Preferred Stock454.8k$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionCommon Stock, $0.001 par value per share2.2M$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionCommon Stock, $0.001 par value per share1.2M$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionCommon Stock, $0.001 par value per share454.8k$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionCommon Stock, $0.001 par value per share298.9k$0.00$0See Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXPurchaseCommon Stock, $0.001 par value per share12.5k$16.00$200kSee Footnotes06/16/2020
06/16/2020Vaxcyte, Inc.PCVXConversionSeries D Preferred Stock298.9k$0.00$0See Footnotes06/16/2020
06/11/2020Vaxcyte, Inc.PCVXGrantStock option (right to buy)40k$16.00$640k 06/11/2020
06/11/2020Vaxcyte, Inc.PCVXGrantStock option (right to buy)40k$16.00$640k 06/11/2020
05/15/2020CymaBay Therapeutics, Inc.CBAYGrantStock Option (Right to Buy)49.2k$4.05$199.4k 05/15/2020
01/29/2019CymaBay Therapeutics, Inc.CBAYGrantStock option (right to buy)27.7k$8.43$233.6k 01/29/2019
12/18/2018CRISPR Therapeutics AGCRSPSaleCommon Shares62.9k$29.70$1.9MSee Footnote12/18/2018
12/18/2018CymaBay Therapeutics, Inc.CBAYSaleCommon Stock53.5k$7.43$397.4kSee footnotes12/17/2018
12/18/2018CRISPR Therapeutics AGCRSPSaleCommon Shares69.9k$29.70$2.1MSee Footnote12/17/2018
12/17/2018CRISPR Therapeutics AGCRSPSaleCommon Shares3k$33.17$99.8kSee Footnote12/17/2018
12/17/2018CymaBay Therapeutics, Inc.CBAYSaleCommon Stock88.9k$8.17$726.2kSee footnotes12/17/2018
06/15/2018CRISPR Therapeutics AGCRSPGrantStock Option (Right to Buy)15k$59.31$889.6k 06/15/2018
06/05/2018CymaBay Therapeutics, Inc.CBAYExercise (in-the-money or at-the-money)Warrant (right to buy)2k$5.75$11.5kBy The Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 200506/05/2018
06/05/2018CRISPR Therapeutics AGCRSPExercise (in-the-money or at-the-money)Warrant (right to buy)2k$5.75$11.5kBy The Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 200506/05/2018
06/05/2018CymaBay Therapeutics, Inc.CBAYSaleCommon Stock920$12.51$11.5kBy the Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 200506/05/2018
06/05/2018CRISPR Therapeutics AGCRSPSaleCommon Stock920$12.51$11.5kBy the Konrad Hans von Emster III and Elizabeth F. von Emster Revocable Trust dated January 18, 200506/05/2018
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy